Additive risk survival model with microarray data

BMC Bioinformatics

Table 2 DLBCL data: genes with nonzero estimates.

UNIQID	Official Symbol	Gene Name	Estimate	OI
27774	CDK7	Hs.184298, cyclin-dependent kinase 7	-0.045	0.333
26627	SMYD5	Hs.54413, retinoic acid induced 15	0.023	0.604
27556	CPR2	Hs.347349, cell cycle progression 2 protein	0.029	0.017
16804			0.015	0.004
31561	LDHA	Hs.2795, lactate dehydrogenase A	-0.009	0.346
16480	NME1	Hs.118638, non-metastatic cells 1,	0.036	0.938
		protein (NM23A) expressed i
29610	IGFALS	Hs.839, insulin-like growth factor binding protein,	0.006	0.013
		acid labile subunit
28383	CR2	Hs.73792, complement component receptor 2	-0.013	0.054
17804	HLA-DMB	Hs.77522, major histocompatibility complex,	-0.032	0.021
		class II, DM alpha
17280	HLA-DRB1	Hs.73931, major histocompatibility complex,	-0.013	0.004
		class II, DQ beta 1
16359	PTK2	Hs.740, PTK2 protein tyrosine kinase 2	-0.041	0.225
29650	MFHAS1	Hs.24724, malignant fibrous histiocytoma	-0.040	0.379
		amplified sequence 1
27593	MMP2	Hs.111301, matrix metalloproteinase 2	-0.021	0.000
16754	MMP2	Hs.111301, matrix metalloproteinase 2	-0.012	0.358
15937	ST14	Hs.119222, suppression of tumorigenicity 13	0.012	0.104
		(colon carcinoma)
28840	EDN1	Hs.2271, endothelin 1	0.019	0.000
30130		Hs.96557, Homo sapiens cDNA FLJ12727 fis,	0.010	0.000
		clone NT2RP2000027

ISSN: 1471-2105